Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: HIV Prevention Projects for Young Men of Color Who Have Sex With Men and Young Transgender Persons of Color, Funding Opportunity Announcement (FOA) PS06-618, 34374 [E6-9270]

Download as PDF 34374 Federal Register / Vol. 71, No. 114 / Wednesday, June 14, 2006 / Notices The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 8, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–9269 Filed 6–13–06; 8:45 am] BILLING CODE 4163–18–P and Prevention, 1600 Clifton Road NE., MS E–07, Atlanta, GA 30333, Telephone 404.639.8531. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 8, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–9270 Filed 6–13–06; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: HIV Prevention Projects for Young Men of Color Who Have Sex With Men and Young Transgender Persons of Color, Funding Opportunity Announcement (FOA) PS06–618 Centers for Disease Control and Prevention In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: rwilkins on PROD1PC63 with NOTICES Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: HIV Prevention Projects for Young Men of Color Who Have Sex With Men and Young Transgender Persons of Color, FOA PS06–618. Times and Dates: 9 a.m.–12 p.m., June 26, 2006 (Closed). 9 a.m.–5 p.m., June 27, 2006 (Closed). 9 a.m.–5 p.m., June 28, 2006 (Closed). 9 a.m.–5 p.m., June 29, 2006 (Closed). 9 a.m.–5 p.m., June 30, 2006 (Closed). Place: W Hotel Atlanta at Perimeter Center, 111 Perimeter Center West, Atlanta, Georgia 30346, Telephone 770.396.6800. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to ‘‘HIV Prevention Projects for Young Men of Color Who Have Sex With Men and Young Transgender Persons of Color,’’ FOA PS06–618. For Further Information Contact: Beth Wolfe, Resource Funding Analyst, Funding Activities Services Office, Extramural Funding Activities Unit, National Center for HIV, STD, and TB Prevention, Centers for Disease Control VerDate Aug<31>2005 19:47 Jun 13, 2006 Jkt 208001 Request Form’’ and register online at https://www.cdc.gov/nip/acip. The access request form can be obtained by contacting Demetria Gardner at 1–404–639–8836 and should be e-mailed upon completion directly to Ms. Gardner at dgardner@cdc.gov. For Further Information Contact: Demetria Gardner, Immunization Services Division, National Center for Immunization and Respiratory Diseases (proposed), CDC, 1600 Clifton Road, NE., (E–05), Atlanta, Georgia 30333, telephone 404/639–8836, fax 404/ 639–8905. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 8, 2006. B. Kathy Skipper, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–9266 Filed 6–13–06; 8:45 am] BILLING CODE 4163–18–P Advisory Committee on Immunization Practices: Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following Federal Committee meeting. Correction: This notice was published in the Federal Register on June 9, 2006, volume 71, number 111, pages 33456– 33457. ‘‘Additional Information’’ that was published on April 3, 2006, volume 71, number 63, page 16582, and a change to the ‘status’ has been added. Name: Advisory Committee on Immunization Practices (ACIP). Times and Dates: 8 a.m.–6 p.m., June 29, 2006. 8 a.m.–4 p.m., June 30, 2006. Place: Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Building 19 (Global Communications Center), Room 232, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Meeting space accommodates approximately 330 people. Overflow space for real-time viewing will be available. Additional Information: In order to expedite the security clearance process at the CDC Clifton Road Campus, all ACIP attendees are now required to register online at https://www.cdc.gov/nip/acip, which can be found under the ‘‘Upcoming Meetings’’ tab. Please be sure to complete all the required fields before submitting your registration and submit no later than June 22, 2006. Please Note: All non-U.S. Citizens must pre-register by June 18, 2006 or they will not be allowed access to the campus and will not be allowed to register on site. All non-U.S. Citizens are required to complete the ‘‘Access PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2002E–0100] Determination of Regulatory Review Period for Purposes of Patent Extension; DUTASTERIDE AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) has determined the regulatory review period for DUTASTERIDE and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of Patents and Trademarks, Department of Commerce, for the extension of a patent that claims that human drug product. ADDRESSES: Submit written comments and petitions to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments to https:// www.fda.gov/dockets/ecomments. FOR FURTHER INFORMATION CONTACT: Beverly Friedman, Office of Regulatory Policy (HFD–7), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–594–2041. SUPPLEMENTARY INFORMATION: The Drug Price Competition and Patent Term Restoration Act of 1984 (Public Law 98– E:\FR\FM\14JNN1.SGM 14JNN1

Agencies

[Federal Register Volume 71, Number 114 (Wednesday, June 14, 2006)]
[Notices]
[Page 34374]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-9270]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: HIV Prevention Projects for Young Men of Color Who Have 
Sex With Men and Young Transgender Persons of Color, Funding 
Opportunity Announcement (FOA) PS06-618

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel: HIV Prevention Projects for Young Men of 
Color Who Have Sex With Men and Young Transgender Persons of Color, 
FOA PS06-618.
    Times and Dates:

9 a.m.-12 p.m., June 26, 2006 (Closed).
9 a.m.-5 p.m., June 27, 2006 (Closed).
9 a.m.-5 p.m., June 28, 2006 (Closed).
9 a.m.-5 p.m., June 29, 2006 (Closed).
9 a.m.-5 p.m., June 30, 2006 (Closed).

    Place: W Hotel Atlanta at Perimeter Center, 111 Perimeter Center 
West, Atlanta, Georgia 30346, Telephone 770.396.6800.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
``HIV Prevention Projects for Young Men of Color Who Have Sex With 
Men and Young Transgender Persons of Color,'' FOA PS06-618.
    For Further Information Contact: Beth Wolfe, Resource Funding 
Analyst, Funding Activities Services Office, Extramural Funding 
Activities Unit, National Center for HIV, STD, and TB Prevention, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS 
E-07, Atlanta, GA 30333, Telephone 404.639.8531.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: June 8, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E6-9270 Filed 6-13-06; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.